Skip to main content
. 2019 Jul 30;10(46):4761–4775. doi: 10.18632/oncotarget.27109

Figure 1. Intracytoplasmic delivery of siRNA by peptide nanoparticles in pancreatic and colorectal cancer is spatially separate from lysosomes and highly efficient.

Figure 1

(A) Confocal microscopy demonstrates diffuse cell uptake of fluorescent tagged siRNA bearing NPs (pink) at 12 hours in CT26 cancer cells (cell wall cyan). (B) Confocal microscopy focusing on a single KPC-1 cancer cell (cell wall cyan) demonstrates accumulation of fluorescent signal (pink) in the cytoplasmic compartment, distinct from lysosomes (yellow), after administration of fluorescent siRNA-bearing peptide NPs. (C) Representative flow cytometry plot showing penetration of siRNA into the cytoplasm of KPC-1 pancreatic cancer.